Bernd Seizinger, M.D., Ph.D., has served asa member of our board of directors since 2016. Dr. Seizinger currently serves as chairman/board member in a number of public and private biotech companies in the U.S., Europe and Canada, including: Oxford BioTherapeutics, Aprea, CryptoMedix, Oncolytics and Biolnvent. Previously he was President & CEO of GPC Biotech; VP Oncology Drug Discovery and - in parallel - VP Corporate and Academic Alliances at Bristol-Myers Squibb; Executive VP and CSO, Genome Therapeutics; Senior Faculty positions at Harvard Medical School, Massachusetts General Hospital and Princeton University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices